Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.
Pharmaceutical manufacturing encompasses all processes involved in the manufacturing and production of biological and medical products, botanical drugs, and herbs, as well as other pharmaceutical ...
The CDMO Sector Holds a Core Position in the Pharmaceutical Industry As a major part of the outsourcing pharmaceutical service industry, CDMOs support pharmaceutical companies across the entire chain, ...
When President Donald Trump announced 10% global tariffs in April, the pharma industry remained largely unscathed. However, the president has since threatened to slap additional tariffs on ...
Key market opportunities include identifying emerging trends and innovations, leveraging insights from recent mergers and acquisitions, optimizing supplier selection, staying informed about regulatory ...
Shardul Nautiyal, Mumbai Friday, January 2, 2026, 08:00 Hrs [IST] ...
The pharmaceutical industry is poised for a dynamic year in 2025. A confluence of positive trends suggests a brighter outlook ahead after declining earnings in recent years. According to ZS consultant ...
NEW YORK, NEW YORK - MARCH 12: CEO of Eli Lilly and Company David Ricks speaks at the Economic Club of New York on March 12, 2024 in New York City. The U.S. drugmaker Eli Lilly, has made strategic ...
Historically, pharmaceutical products have been produced in a traditional ‘batch’ system, in which every operation is executed separately using a defined quantity of materials. In batch manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback